These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9894765)

  • 1. Genetic testing for breast cancer susceptibility: Polish women's attitudes.
    Braczkowski R; Nowakowska-Zajdel E; Zubelewicz B; Muc-Wierzgon M; Romanowski W
    J Exp Clin Cancer Res; 1998 Sep; 17(3):299-302. PubMed ID: 9894765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral risk factors among women presenting for genetic testing.
    Emmons KM; Kalkbrenner KJ; Klar N; Light T; Schneider KA; Garber JE
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):89-94. PubMed ID: 10667468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge.
    Bottorff JL; Ratner PA; Balneaves LG; Richardson CG; McCullum M; Hack T; Chalmers K; Buxton J
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):89-95. PubMed ID: 11815405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.
    Hopper JL; Southey MC; Dite GS; Jolley DJ; Giles GG; McCredie MR; Easton DF; Venter DJ
    Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):741-7. PubMed ID: 10498392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with decisions about clinical BRCA1/2 testing.
    Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
    Geller G; Doksum T; Bernhardt BA; Metz SA
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitude towards genetic testing for breast cancer susceptibility: a comparison of affected and unaffected women.
    Bruno M; Digennaro M; Tommasi S; Stea B; Danese T; Schittulli F; Paradiso A
    Eur J Cancer Care (Engl); 2010 May; 19(3):360-8. PubMed ID: 19912305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct-to-patient BRCA1 testing: the Twoj Styl experience.
    Gronwald J; Huzarski T; Byrski T; Debniak T; Metcalfe K; Narod SA; Lubiński J
    Breast Cancer Res Treat; 2006 Dec; 100(3):239-45. PubMed ID: 16807675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Breast cancer genetics. BRCA1 and BRCA2: the main genes for disease predisposition].
    Ruiz-Flores P; Calderón-Garcidueñas AL; Barrera-Saldaña HA
    Rev Invest Clin; 2001; 53(1):46-64. PubMed ID: 11332051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary breast cancer: high risk genes, genetic testing and clinical implications.
    Hamann U
    Clin Lab; 2000; 46(9-10):447-61. PubMed ID: 11034530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interest in genetic testing among first-degree relatives of breast cancer patients.
    Lerman C; Seay J; Balshem A; Audrain J
    Am J Med Genet; 1995 Jul; 57(3):385-92. PubMed ID: 7677139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer.
    Gershoni-Baruch R; Dagan E; Fried G; Kepten I; Robinson E
    Eur J Hum Genet; 1999; 7(7):833-6. PubMed ID: 10573018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
    Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
    Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Generic screening for breast cancer].
    Ponti A; Giordano L
    Epidemiol Prev; 1999; 23(4):369-71. PubMed ID: 10730478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes toward the genetic testing of children among adults in a Utah-based kindred tested for a BRCA1 mutation.
    Hamann HA; Croyle RT; Venne VL; Baty BJ; Smith KR; Botkin JR
    Am J Med Genet; 2000 May; 92(1):25-32. PubMed ID: 10797419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women's knowledge and attitudes about genetic testing for breast cancer susceptibility.
    Ludman EJ; Curry SJ; Hoffman E; Taplin S
    Eff Clin Pract; 1999; 2(4):158-62. PubMed ID: 10539540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
    Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
    CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer.
    Grzybowska E; Zientek H; Jasinska A; Rusin M; Kozlowski P; Sobczak K; Sikorska A; Kwiatkowska E; Gorniak L; Kalinowska E; Utracka-Hutka B; Wloch J; Chmielik E; Krzyzosiak WJ
    Hum Mutat; 2000 Dec; 16(6):482-90. PubMed ID: 11102977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary breast cancer.
    Robson ME; Boyd J; Borgen PI; Cody HS
    Curr Probl Surg; 2001 Jun; 38(6):387-480. PubMed ID: 11375625
    [No Abstract]   [Full Text] [Related]  

  • 20. The quality of life associated with prophylactic treatments for women with BRCA1/2 mutations.
    Grann VR; Jacobson JS; Sundararajan V; Albert SM; Troxel AB; Neugut AI
    Cancer J Sci Am; 1999; 5(5):283-92. PubMed ID: 10526669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.